DARAXONRASIB
UNII B6T47Y2UAP

Substance Identification & Data

This profile provides standardized clinical and technical data for Daraxonrasib, uniquely identified by the FDA Unique Ingredient Identifier (UNII) B6T47Y2UAP.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2765081-21-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

B6T47Y2UAP

CAS Registry Number

2765081-21-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

DARAXONRASIB

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C44H58N8O5S

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

FVICRBSEYSHKFY-JYQNNKODSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C188048

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

164726578

Unique identification number in the NCBI database of chemical substances.

INN ID

13270

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

OP-26

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C1N(CCN(c2cc(c(nc2)[C@@H](OC)C)-c3n(CC)c4ccc5-c6csc(n6)C[C@@H](C(=O)N7CCC[C@H](N7)C(OCC(Cc3c4c5)(C)C)=O)NC([C@H]8C[C@@H]8C)=O)C1)C

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Daraxonrasib. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

DARAXONRASIB

Common Names & Synonyms

DARAXONRASIB [INN]

DARAXONRASIB [USAN]

RMC 6236 [WHO-DD]

Systematic Nomenclature

(1S,2S)-N-((12M,4S,63S)-11-ETHYL-12-(2-((1S)-1-METHOXYETHYL)-5-(4-METHYLPIPERAZIN-1-YL)PYRIDIN-3-YL)-10,10-DIMETHYL-5,7-DIOXO-11H-8-OXA-1(5,3)-INDOLA-6(1,3)-(1,2)DIAZINANA-2(4,2)-(1,3)THIAZOLACYCLOUNDECAPHAN-4-YL)-2-METHYLCYCLOPROPANE-1-CARBOXAMIDE

SYS

CYCLOPROPANECARBOXAMIDE, N-((2R,14S,18S)-1-ETHYL-18,19,20,21-TETRAHYDRO-2-(2-((1S)-1-METHOXYETHYL)-5-(4-METHYL-1-PIPERAZINYL)-3-PYRIDINYL)-25,25-DIMETHYL-15,22-DIOXO-17H-5,3-((4,2)-ENDO-THIAZOLOPROPANO(1,3)-ENDO-PYRIDAZINOMETHANOXYPROPANO)-1H-INDOL-14-YL)-2-METHYL-, (1S,2S)-

SYS